Shares of INLIF Ltd (NASDAQ:INLF) rose sharply in pre-market trading after the company reported a 26.01% net revenue rise in its unaudited first-half fiscal 2026 results.

Net revenue of $12.94 million was up from $10.27 million a year earlier. Gross profit for INLIF rose 158.77% to $4.65 million, while gross margin expanded to 35.95% from 17.50%. The company also posted net income of $1.01 million, reversing a $1.98 million loss in the prior-year period.

INLIF shares jumped 78% to $5.25 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

• Cheetah Net Supply Chain Service Inc (NASDAQ:CTNT) rose 53.3% to $0.049 in pre-market trading after dropping over 40% on Thursday.
• Onconetix Inc (NASDAQ:ONCO) rose 29.6% to $1.18 in pre-market trading.
• Infobird Co Ltd (NASDAQ:IFBD) gained 23% to $1.39 in pre-market trading after the Hong Kong-based Chinese software-as-a-service (SaaS) provider announced unaudited financial results for the six months ended Jun. 30.
• Fathom Holdings Inc (NASDAQ:FTHM) rose 16.4% to $0.60 in pre-market trading following news of a revised merger structure with data and technology holding company Neighborhood Intelligence Inc. (NASDAQ:NXH).
• Greenland Energy Co (NASDAQ:GLND) gained 22.6% to $6.56 in pre-market trading. Greenland Energy shares jumped 84% on Thursday after the company announced extension of Jameson Land Farm-Out Agreement with 80 Mile plc.
• Akamai Technologies Inc (NASDAQ:AKAM) gained 21% to $133.60 in pre-market trading after the company announced expanded relationship with Anthropic for $11.6 billion of contractual commitment over seven years.
• SU Group Holdings Ltd (NASDAQ:SUGP) rose 19.2% to $0.56 in pre-market trading. The company recently secured exclusive HDX X-ray distribution rights in Hong Kong and Macau and agreed to acquire KM Safety Solution Company Limited for $721,000.
• Atlas Energy Solutions Inc (NYSE:AESI) gained 13.8% to $12.50 in pre-market trading. Atlas Energy Solutions Shackelford 1, LLC entered into a Purchase Agreement with Wyoming Machinery Company d/b/a Energy Solutions, for the purchase of balance-of-plant equipment for a specific power generation project.
• Prime Medicine, Inc (NASDAQ:PRME) gained 9.5% to $3.36 in pre-market trading as the company announced the FDA clearance of its Investigational New Drug application for PM647 in Alpha-1 antitrypsin deficiency.

Losers

• Traws Pharma Inc (NASDAQ:TRAW) tumbled 15.7% to $0.47 in pre-market trading after gaining 11% on Thursday.
• LZ Technology Holdings Ltd (NASDAQ:LZMH) fell 14.6% to $0.98 in pre-market trading after declining 4% on Thursday.
• Powell Max Limited (NASDAQ:PMAX) fell 14.5% to $1.4103 in pre-market trading after surging over 80% on Thursday.
• Stak Inc (NASDAQ:STAK) fell 13.7% to $1.24 in pre-market trading after jumping 35% on Thursday.
• Banzai International, Inc. (NASDAQ:PARA) fell 13.1% to $0.7120 in pre-market trading after declining 7% on Thursday.
• Legacy Education Inc. (NYSE:LGCY) declined 13.1% to $9.25 in pre-market trading after the company reported fourth-quarter and full fiscal 2026 financial results.
• Scholastic Corporation (NASDAQ:SCHL) fell 9.9% to $31.38 in pre-market trading after the company reported downbeat results for the first quarter.
• Top Wealth Group Holding Limited (NASDAQ:TWG) fell 9.3% to $0.1860 in pre-market trading after dipping 24% on Thursday. Top Wealth recently said net profit attributable to shareholders is expected to rise at least 100% year-over-year for fiscal 2026.
• YD Bio Ltd (NASDAQ:YDES) fell 5.1% to $4.53 in pre-market trading after jumping 48% on Thursday.
• Surrozen, Inc. (NASDAQ:SRZN) fell 4.7% to $32.11 in pre-market trading. Surrozen shares jumped 108% on Thursday after the company submitted an Investigational New Drug application to the U.S. Food and Drug Administration to evaluate SZN-8141 for treating diabetic macular edema.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.